Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
27.15
+0.49 (1.84%)
Oct 9, 2025, 3:58 PM EDT
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $50.44 billion as of October 9, 2025. Its market cap has decreased by -25.79% in one year.
Market Cap
50.44B
Enterprise Value
48.01B
Revenue
13.34B
Ranking
n/a
PE Ratio
24.60
Stock Price
$27.15
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 50.44B, an increase of 1,623.89%. That is a compound annual growth rate of 15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 50.61B | -2.96% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | 66.36B | 54.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 277.90M |
| Silence Therapeutics | 242.78M |